Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Vesicles | 4 | 2023 | 59 | 2.010 |
Why?
|
| Ischemia | 6 | 2024 | 263 | 1.360 |
Why?
|
| Retina | 3 | 2021 | 221 | 1.180 |
Why?
|
| Lung Injury | 4 | 2023 | 61 | 1.010 |
Why?
|
| Retinal Diseases | 3 | 2023 | 80 | 0.950 |
Why?
|
| Lung | 12 | 2023 | 1408 | 0.930 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2013 | 41 | 0.820 |
Why?
|
| Ischemic Postconditioning | 2 | 2020 | 10 | 0.760 |
Why?
|
| Culture Media, Conditioned | 2 | 2019 | 102 | 0.680 |
Why?
|
| Beclin-1 | 1 | 2020 | 15 | 0.630 |
Why?
|
| Retinal Vessels | 2 | 2018 | 54 | 0.620 |
Why?
|
| Acute Lung Injury | 4 | 2018 | 73 | 0.610 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 66 | 0.600 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 270 | 0.580 |
Why?
|
| Autophagy | 2 | 2020 | 177 | 0.570 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 94 | 0.540 |
Why?
|
| Bleomycin | 2 | 2015 | 102 | 0.540 |
Why?
|
| Sphingosine | 4 | 2013 | 73 | 0.540 |
Why?
|
| MicroRNAs | 1 | 2023 | 608 | 0.530 |
Why?
|
| Lysophospholipids | 3 | 2013 | 67 | 0.520 |
Why?
|
| Retinal Degeneration | 1 | 2017 | 30 | 0.510 |
Why?
|
| Glucose | 1 | 2020 | 704 | 0.500 |
Why?
|
| Radiation Injuries | 2 | 2023 | 160 | 0.470 |
Why?
|
| Rats | 7 | 2023 | 4074 | 0.470 |
Why?
|
| Oxygen | 1 | 2020 | 773 | 0.440 |
Why?
|
| Animals | 26 | 2024 | 28981 | 0.440 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2013 | 3 | 0.400 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 8 | 0.400 |
Why?
|
| Gamma Rays | 1 | 2013 | 72 | 0.390 |
Why?
|
| Sphingolipids | 2 | 2023 | 21 | 0.390 |
Why?
|
| Retinal Ganglion Cells | 3 | 2024 | 73 | 0.380 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 53 | 0.380 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 420 | 0.380 |
Why?
|
| Pulmonary Fibrosis | 4 | 2015 | 158 | 0.360 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2013 | 38 | 0.340 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 755 | 0.330 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 25 | 0.330 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 2023 | 0.330 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 50 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 2577 | 0.320 |
Why?
|
| Astrocytes | 2 | 2021 | 142 | 0.310 |
Why?
|
| Simvastatin | 1 | 2010 | 106 | 0.300 |
Why?
|
| Rats, Wistar | 3 | 2020 | 304 | 0.300 |
Why?
|
| Intravitreal Injections | 2 | 2021 | 69 | 0.290 |
Why?
|
| Mice | 15 | 2024 | 12735 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 3616 | 0.280 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 42 | 0.250 |
Why?
|
| Macrophages | 2 | 2007 | 643 | 0.240 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 406 | 0.240 |
Why?
|
| Disease Progression | 1 | 2010 | 1615 | 0.230 |
Why?
|
| Trachea | 1 | 2007 | 246 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 370 | 0.230 |
Why?
|
| Endothelial Cells | 4 | 2023 | 502 | 0.220 |
Why?
|
| Capillary Permeability | 5 | 2018 | 133 | 0.220 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2024 | 362 | 0.220 |
Why?
|
| Reperfusion Injury | 2 | 2024 | 148 | 0.220 |
Why?
|
| Hypoxia | 2 | 2023 | 682 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2013 | 2212 | 0.210 |
Why?
|
| Epithelial Cells | 2 | 2018 | 710 | 0.210 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2013 | 64 | 0.210 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2013 | 136 | 0.200 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 525 | 0.180 |
Why?
|
| Optic Neuritis | 1 | 2021 | 9 | 0.180 |
Why?
|
| Cell Line | 3 | 2019 | 2483 | 0.180 |
Why?
|
| Neuromyelitis Optica | 1 | 2021 | 24 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 1178 | 0.170 |
Why?
|
| Retinal Neurons | 1 | 2021 | 11 | 0.170 |
Why?
|
| Fluorescence | 1 | 2021 | 100 | 0.170 |
Why?
|
| Particulate Matter | 2 | 2012 | 138 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1255 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2021 | 161 | 0.160 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2858 | 0.160 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2017 | 122 | 0.160 |
Why?
|
| Electroretinography | 2 | 2017 | 82 | 0.160 |
Why?
|
| Microglia | 1 | 2021 | 131 | 0.150 |
Why?
|
| Lysosomes | 1 | 2020 | 126 | 0.150 |
Why?
|
| Cell Death | 1 | 2020 | 258 | 0.150 |
Why?
|
| Signal Transduction | 5 | 2018 | 3633 | 0.140 |
Why?
|
| Cytokines | 1 | 2023 | 891 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 215 | 0.140 |
Why?
|
| Kinetics | 1 | 2021 | 1477 | 0.140 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2018 | 30 | 0.140 |
Why?
|
| Sulfones | 1 | 2018 | 48 | 0.140 |
Why?
|
| Quinolones | 1 | 2018 | 57 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 2471 | 0.130 |
Why?
|
| Blood-Retinal Barrier | 1 | 2017 | 3 | 0.130 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 205 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 2 | 2007 | 102 | 0.130 |
Why?
|
| Eye Proteins | 1 | 2018 | 131 | 0.130 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 37 | 0.120 |
Why?
|
| Radiation | 1 | 2015 | 16 | 0.120 |
Why?
|
| Aldehyde-Lyases | 1 | 2015 | 14 | 0.110 |
Why?
|
| Free Radical Scavengers | 2 | 2012 | 59 | 0.110 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2014 | 4 | 0.110 |
Why?
|
| Inflammation | 2 | 2024 | 1133 | 0.100 |
Why?
|
| Thiophenes | 2 | 2011 | 46 | 0.100 |
Why?
|
| Oxadiazoles | 2 | 2011 | 42 | 0.100 |
Why?
|
| Acyltransferases | 1 | 2014 | 57 | 0.100 |
Why?
|
| Apoptosis | 2 | 2017 | 1752 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 639 | 0.100 |
Why?
|
| Collagen | 1 | 2015 | 313 | 0.100 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 10 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 23 | 0.100 |
Why?
|
| Propylene Glycols | 1 | 2013 | 30 | 0.100 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2014 | 240 | 0.100 |
Why?
|
| Oxidants | 1 | 2013 | 86 | 0.100 |
Why?
|
| Gene Deletion | 2 | 2011 | 355 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 173 | 0.090 |
Why?
|
| TRPM Cation Channels | 1 | 2012 | 9 | 0.090 |
Why?
|
| Humans | 13 | 2023 | 98362 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1791 | 0.090 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2012 | 4 | 0.090 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2012 | 15 | 0.090 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.090 |
Why?
|
| Calpain | 1 | 2012 | 113 | 0.090 |
Why?
|
| Microvessels | 1 | 2012 | 70 | 0.090 |
Why?
|
| Hydrogen Sulfide | 1 | 2012 | 54 | 0.090 |
Why?
|
| Ceramides | 1 | 2011 | 36 | 0.080 |
Why?
|
| Male | 8 | 2020 | 47257 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 54 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2012 | 116 | 0.080 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 27 | 0.080 |
Why?
|
| Radiation Pneumonitis | 1 | 2010 | 23 | 0.080 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 44 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 440 | 0.080 |
Why?
|
| Brain Death | 1 | 2011 | 94 | 0.080 |
Why?
|
| Mitochondria | 1 | 2014 | 650 | 0.080 |
Why?
|
| Electric Impedance | 3 | 2018 | 118 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 80 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2013 | 1290 | 0.080 |
Why?
|
| Blood-Air Barrier | 1 | 2009 | 6 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 642 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 583 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 559 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 770 | 0.070 |
Why?
|
| Female | 6 | 2018 | 51756 | 0.070 |
Why?
|
| Prostaglandin D2 | 1 | 2007 | 28 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2007 | 35 | 0.060 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 313 | 0.060 |
Why?
|
| Gene Expression | 2 | 2011 | 1322 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2015 | 357 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 78 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2018 | 1145 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2007 | 118 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2015 | 743 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2007 | 341 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2007 | 420 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1133 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2007 | 447 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2896 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2007 | 424 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 682 | 0.050 |
Why?
|
| Reperfusion | 1 | 2024 | 33 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 213 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 74 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2023 | 95 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 10 | 0.040 |
Why?
|
| Pneumonia | 2 | 2013 | 195 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2018 | 11 | 0.030 |
Why?
|
| Biomarkers | 2 | 2014 | 2021 | 0.030 |
Why?
|
| Injections, Intraocular | 1 | 2016 | 5 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 5576 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 272 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 42 | 0.030 |
Why?
|
| Cardiolipins | 1 | 2014 | 18 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 306 | 0.030 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2013 | 13 | 0.020 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2013 | 30 | 0.020 |
Why?
|
| Permeability | 1 | 2012 | 145 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2015 | 766 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 256 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2012 | 73 | 0.020 |
Why?
|
| Thorax | 1 | 2012 | 77 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 123 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1568 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 34 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1817 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 212 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 679 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 526 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1945 | 0.020 |
Why?
|
| Drug Inverse Agonism | 1 | 2009 | 3 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2009 | 20 | 0.020 |
Why?
|
| Body Fluids | 1 | 2009 | 35 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 403 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1785 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 489 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 402 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1647 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2017 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2070 | 0.020 |
Why?
|
| Endotoxins | 1 | 2007 | 36 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 713 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 1203 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 3227 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 427 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1947 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1561 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21844 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 29532 | 0.010 |
Why?
|